Cervical cancer (CC) treatments impact quality of life (QoL) and sexual function (SF) of survivors. Treatment options to reduce sexual dysfunction are limited. The aim of this study was to assess the effectiveness of ospemifene in CC survivors with clinical signs and symptoms of vulvovaginal atrophy (VVA) focusing on their QoL and SF.
Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study / DE ROSA, Nicoletta; Lavitola, Giada; Giampaolino, Pierluigi; Morra, Ilaria; Nappi, Carmine; Bifulco, Giuseppe. - In: BIOMED RESEARCH INTERNATIONAL. - ISSN 2314-6133. - 2017:(2017), p. 7513610. [10.1155/2017/7513610]
Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study
DE ROSA, NICOLETTA;GIAMPAOLINO, PIERLUIGI;MORRA, ILARIA;NAPPI, CARMINE;BIFULCO, GIUSEPPE
2017
Abstract
Cervical cancer (CC) treatments impact quality of life (QoL) and sexual function (SF) of survivors. Treatment options to reduce sexual dysfunction are limited. The aim of this study was to assess the effectiveness of ospemifene in CC survivors with clinical signs and symptoms of vulvovaginal atrophy (VVA) focusing on their QoL and SF.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
